Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
Ahmed Bennis, Professor of Cardiology at Ibn Rochd University Hospital, shared on X։
”The Role of Coronary Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction․
CMD is an independent predictor for future adverse outcomes in the HFpEF population.
CMD and HFpEF share pathophysiological links, although a direct causal relationship remains unproven.
Comprehensive CMD assessment in HFpEF can improve risk stratification and guide targeted therapeutic strategies.”
Read the full article here.
Article: The Role of Coronary Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
Authors: Andreas Tzoumas, Danielle Tapp, Daniela Crousillat, Michael C. Honigberg, Patricia F. Rodriguez-Lozano, Niti R. Aggarwal, Imo A. Ebong, Joan Briller, Glaucia Moraes De Oliveira, Colleen M. Harrington, Selma F. Mohammed, Noel Bairey Merz, Timothy D. Henry, and Odayme Quesada
Stay updated with Hemostasis Today.
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis
-
Jan 12, 2026, 01:45Khurram Nasir on Where The Cholesterol Guidelines Are Headed